Trypanosoma lewisi-induced immunosuppression: The effects on alveolar macrophage activities against Cryptococcus neoformans

Experimental Parasitology

Volumn 113, Issue 4, 2006, Pages 262-266

  Gross, Norma Teresa ^a   Guerrero, Olga Marta ^a   Chinchilla, Misael ^a   Jarstrand Hall, Connie ^b  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alveolar macrophages; Cryptococcus neoformans; Immunosuppression; Trypanosoma lewisi

Indexed keywords

NITROBLUE TETRAZOLIUM; SUPEROXIDE;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CELL ADHESION; CELL SURVIVAL; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FLUORESCENCE; FUNGAL CELL; FUNGUS CULTURE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY; TRYPANOSOMA LEWISI;

ANIMALS; CELL SURVIVAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; IMMUNOCOMPROMISED HOST; INDICATORS AND REAGENTS; MACROPHAGES, ALVEOLAR; MALE; NITROBLUE TETRAZOLIUM; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; TRYPANOSOMA LEWISI; TRYPANOSOMIASIS;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; TRYPANOSOMA LEWISI;

EID: 33745933635     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2006.02.002     Document Type: Article

References (39)

1. Albright J.W., and Albright J.F. Rodent trypanosomes: Their conflict with the immune system of the host. Parasitology Today 7 (1991) 137-140
2. Berstein B., Flomenberg P., and Letzer D. Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS. Southern Medical Journal 87 (1994) 537-538
3. Catarinella G., Chinchilla M., Guerrero O.M., and Castro A. Infection of white rat peritoneal macrophages with Toxoplasma gondii (Coccidia: Sarcocystidae) after Trypanosoma lewisi (kinetoplastida: Trypanosomatidae) infection. Revista de Biologia Tropical 47 (1999) 483-488
4. Cox G.M., Harrison T.S., McDade H.C., Taborda C.P., Heinrich G., Casadevall A., and Perfect J.R. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infection and Immunity 71 (2003) 173-180
5. Datta K., Jain N., Sethi S., Rattan A., Casadevall A., and Baerjee U. Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiaty care centre in India: a need for care. Journal of Antimicrobial Chemotherapy 52 (2003) 683-686
6. Darji A., Lucas R., Magez S., Torreele E., Palacios J., Sileghem M., Bajyana Songa E., Hamers R., and de Baetselier P. Mechanisms underlying trypanosome-elicited immunosuppression. Annales de la Societe Belgue de Medecine Tropicale 72 (1992) 27-38
7. Dupont B., Graybill J.R., Armstrong D., Laroche R., Touzé J.E., and Whea L.J. Fungal infections in AIDS patients. Journal of Medical and Veterinary Mycology 30 (1992) 19-28
8. Goldman D., Lee S.C., and Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infection and Immunity 62 (1994) 4755-4761
9. Goldman D., Cho Y., Zhao M.L., Casadevall A., and Lee S.C. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas. American Journal of Pathology 148 (1996) 1275-1282
10. Graybill J.R., Ahrens J., Nealon T., and Paque R. Pulmonary cryptococcosis in the rat. American Review of Respiratory Diseases 127 (1983) 636-640
11. Gross N.T., Chinchilla M., Camner P., and Jarstrand C. Anticryptococcal activity by alveolar macrophages from rats treated with cortisone acetate during different periods of time. Mycopathologia 136 (1996) 1-8
12. Gross N.T., Jarstrand C., and Robertson B. Treatment of experimental Cryptococcus neoformans infection in newborn rabbits by airway instillation of specific antibody surfactant. Letters of Applied Microbiology 3 (2000) 218-222
13. Gross N.T., Nessa K., Camner P., Chinchilla M., and Jarstrand C. Interaction between Cryptococcus neoformans and alveolar macrophages. Journal of Medical and Veterinary Mycology 35 (1997) 263-269
14. Gross N.T., Nessa K., Camner P., and Jarstrand C. Production of nitric oxide by rat alveolar macrophages stimulated by Cryptococcus neoformans or Aspergillus fumigatus. Medical Mycology 37 (1999) 151-157
15. Guerrero O.M., Chinchilla M., and Abrahams E. Increasing of Toxoplasma gondii (Coccidia, Sarcocystidae) infections by Trypanosoma lewisi (Kinetoplastida, Trypanosomatidae) in white rats. Revista de Biologia Tropical 45 (1997) 877-882
16. Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiology Letters 1 (1977) 357-361
17. Jarstrand C. The NBT- (nitroblue tetrazolium) activity of neutrophil granulocytes in patients with influenza A infection. Scandinavian Journal of Infectious Diseases 9 (1977) 5-7
18. Jenny-Avital E.R., and Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antitretroviral therapy. Clinical Infectious Diseases 35 (2002) e128-e133
19. Liu L., Tewari R.P., and Williamson P. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infection and Immunity 67 (1999) 6034-6039
20. Lovchik J.A., Lyons C.R., and Lipscomb M.F. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. American Journal of Respiratory Cell and Molecular Biology 13 (1995) 116-124
21. Luberto C., Martínez-Marino B., Taraskiewicz D., Bolaños B., Chitano P., Toffaletti D.L., et al. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. Journal of Clinical Investigation 112 (2003) 1080-1094
22. Manfredi R., Calza L., and Chiodo F. AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems. International Journal of Antimicrobial Agents 22 (2003) 449-452
23. Mody C., Tyler C., Sitrin R., Jackson C., and Toews G. Interferon γ activates rat alveolar macrophages for anticryptococcal activity. American Journal of Respiratory Cell and Molecular Biology 5 (1991) 19-26
24. Mussini C., Pezzotti P., Miro J.M., Martínez E., de Quiros J.C., Cinque P., et al. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Clinical Infectious Diseases 38 (2004) 565-571
25. Mwaba P., Mwansa J., Chintu C., Pobee J., Scarborough M., Portsmouth S., et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgraduate Medical Journal 77 (2001) 769-773
26. Ndarathi C.M. Cellular responses to culture-derived soluble exoantigens of Trypanosome lewisi. Parasitology Research 78 (1992) 324-328
27. Neilson J.B., Fromtling R.A., and Bulmer G.S. Cryptococcus neoformans: size range of infectious particles from aerosolized soil. Infection and Immunity 17 (1977) 634-638
28. Nyberg K., Nessa K., Johansson A., Jarstrand C., and Camner P. Alveolar macrophage response to yeasts and inert particles. Journal of Medical and Veterinary Mycology 34 (1996) 11-17
29. Perfect J.R., Durak D.T., and Gallis H.A. Cryptococcemia. Medicine 62 (1983) 98-109
30. Rivera J., Mukherjee J., Weiss L.M., and Casadevall A. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. Journal of Immunology 168 (2002) 3419-3427
31. Shapiro S., Beenhouwer D.O., Feldmesser M., Taborda C., Carrol M., Casadevall A., et al. Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infection and Immunnity 70 (2002) 2598-2604
32. Siddiqui A.A., Brouwer A.E., Wuthiekanum V., Jaffar S., Shattock R., Irving D., et al. IFN-gamma at the site of infection determines rate of clearance of infection in Cryptococcal meningitis. Journal of Immunology 174 (2005) 1746-1750
33. Summers S.A., Dorling A., Boyle J.J., and Shaunak S. Cure of disseminated cryptococcal infection in a renal allograft recipient after addition of γ-interferon to antifungal therapy. American Journal of Transplantation 5 (2005) 2067-2069
34. Sztein M.B., and Kierszenbaum F. Mechanisms of development of immunosuppression during trypanosome infections. Parasitology Today 9 (1993) 424-428
35. Trevenzoli M., Cattelan A.M., Rea F., Saaaet L., Semisa M., Lanzafame M., et al. Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. Journal of Infection 45 (2002) 173-179
36. Weinberg P.B., Becker S., Granger D.L., and Koren H.S. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages. American Review of Respiratory Diseases 136 (1987) 1242-1247
37. Venkateswarlu K., Taylor M., Manning N.J., Rinaldi M.G., and Kelly S.L. Fluconazol tolerance in clinical isolates of Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy 41 (1997) 748-751
38. Wu H., Casadevall A., Lee S.C., and Goldman D.L. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infection and Immunity 71 (2003) 930-936
39. Zelings B.J., Nerurkar L.S., and Bellanti J.A. Maturation of the rabbit alveolar macrophage during animal development III. Phagocytic and bactericidal functions. Pediatric Research 11 (1977) 1208-1211